Is Eugenol safe in cosmetics?
Eugenol has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 4 toxicological study endpoint(s) are available in our database.
Also known as: 4-Allylcatechol 2-methyl ether, 5-Allylguaiacol, BRN 1366759, Caswell No. 456BC, EINECS 202-589-1 (+15 more)
INCI: EUGENOL
Eugenol (CAS 97-53-0) is a cosmetic fragrance functioning as fragrance; antimicrobial; anesthetic. NOAEL 525 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 10 ppm in leave-on products, 100 ppm in rinse-off products. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 97-53-0 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Eugenol.
Calculate MoS for your specific formulation with the MoS Calculator.
4 study endpoints found for Eugenol. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 25 mg/kg bw/day | oral | rat | Special Toxicology Study | COSMOS_DB |
| NOAEL | 410.5 mg/kg bw/day | oral | mouse | Short Term Toxicity | COSMOS_DB |
| NOAEL | 500 mg/kg bw/day | oral | rat | Short Term Toxicity | COSMOS_DB |
| NOAEL | 638 mg/kg bw/day | oral | rat | Carcinogenicity | COSMOS_DB |
Pre-calculated NOAEL → SED → MoS audit trail for Eugenol across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Eugenol based on clinical patch test studies and IFRA standards.
Source: ESSCA/IVDK
Skin absorption and penetration characteristics of Eugenol, relevant to systemic exposure and MoS calculations.
Source: SCCS/1459/11, IFRA
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| LD50 | =1930 mg/kg | Rat | oral | - | EFSA |
| LD50 | =1930 mg/kg | Rat | oral | - | EFSA |
| NOAEL | =100 mg/kg-day | Rat | oral | - | EFSA |
| NOAEL | =100 mg/kg-day | Rabbit | oral | - | EFSA |
| NOAEL | =100 mg/kg-day | Rat | oral | - | EFSA |
| NOAEL | =100 mg/kg-day | Rabbit | oral | - | EFSA |
| NOEL | =250 mg/kg-day | Rat | oral | - | EFSA |
| NOAEL | =300 mg/kg-day | Rat | oral | chronic | EFSA |
| NOAEL | =300 mg/kg-day | Rat | oral | chronic | EFSA |
| ADI | <=2.5 mg/kg | Human | oral | - | WHO JECFA ADI |
International Agency for Research on Cancer (WHO) monograph evaluation.
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: Estrada et al. (2003) | Lalko & Api (2006); DPRA: Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030] | Nukada et al. 2013 [DOI:10.1016/j.tiv.2012.11.006]; KS: Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030] | Natsch et al. 2011 [DOI:10.1021/tx2003678]; hCLAT: Bauch et al. 2011 [DOI:10.1016/j.tiv.2011.05.030] | Ashikaga et al. 2010 [DOI:10.1177/026119291003800403]; HPPT: [103] Greif N (1967): Cutaneous safety of fragrance material as measured by the maximization test.
5 human repeat insult patch tests aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HRIPT | 108 | 0 | 5906 | 5906 | non-sensitizer |
| HRIPT | 114 | 0 | 2362 | 2362 | non-sensitizer |
| HRIPT | 104 | 0 | 5906 | 5906 | non-sensitizer |
| HRIPT | - | 0 | 5906 | 5906 | weak |
| HMT | - | 0 | 4965.52 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
weak agonist
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| GCC | restricted | 0.001 | Leave-on products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
Source: EPA_Dryad_Skin_Absorption_2024
Source: Roberts_Cheruvu_Mendeley_2022
International Fragrance Association standards per product category. Restriction: Restriction. Effective: 2024-01-01.
| Category | Max % | Category | Max % |
|---|---|---|---|
| 1 (Lip products) | 0.5% | 7a (Deodorant – not spray) | 1.0% |
| 2 (Body spray) | 0.15% | 7b (Deodorant spray) | 1.0% |
| 3 (Body cream) | 0.5% | 8 (Face cream) | 0.17% |
| 4 (Fine fragrance) | 2.0% | 9 (Soap) | 2.5% |
| 5a (Body lotion) | 0.5% | 10a (Household – non-spray) | 2.5% |
| 5b (Face cream leave-on) | 0.5% | 10b (Household – spray) | No Restriction% |
| 5c (Hand cream) | 0.5% | 11a (Intimate – leave-on) | 0.17% |
| 5d (Baby cream) | 0.17% | 11b (Intimate – rinse) | 0.17% |
| 6 (Mouthwash) | 0.5% | 12 (Not for consumer exposure) | No Restriction% |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Eugenol.
Public NOAEL study rows linked to Eugenol by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Eugenol has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 4 toxicological study endpoint(s) are available in our database.
Eugenol EU regulatory status: restricted. Maximum allowed concentration: 10 ppm in leave-on products, 100 ppm in rinse-off products. This is based on EU Regulation 1223/2009 and its amendments.
Eugenol functions as: fragrance; antimicrobial; anesthetic. It is classified as a Fragrance in our database. CAS number: 97-53-0.
The NOAEL (No Observed Adverse Effect Level) for Eugenol is 25 mg/kg bw/day based on a Special Toxicology Study study via oral route in rat. A total of 4 study endpoints are available. Source: COSMOS_DB.
Eugenol also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Eugenol compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Eugenol in your formulation.